Vanguard Group
AZR

Vanguard Group’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Vanguard Group’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$34.3K Hold
6,241
– – ﹤0.01% 4277
2025
Q3 		$55.2K Buy
6,241
+5,715
+1,087% +$55.7K ﹤0.01% 4289
2025
Q2 		$3.97K Hold
526
– – ﹤0.01% 4267
2025
Q1 		$8.34K Buy
+526
New +$10.9K ﹤0.01% 4260
2023
Q3 		– Sell
-325
Closed -$42.3K – 4539
2023
Q2 		$42.3K Hold
325
– – ﹤0.01% 4475
2023
Q1 		$71.2K Sell
325
-441
-58% -$107K ﹤0.01% 4433
2022
Q4 		$103K Sell
766
-221
-22% -$38.7K ﹤0.01% 4388
2022
Q3 		$216K Buy
987
+42
+4% +$18.9K ﹤0.01% 4404
2022
Q2 		$792K Hold
945
– – ﹤0.01% 4158
2022
Q1 		$1.19M Hold
945
– – ﹤0.01% 4156
2021
Q4 		$1.6M Sell
945
-6
-0.6% -$11.8K ﹤0.01% 4123
2021
Q3 		$2.55M Buy
951
+15
+2% +$31.4K ﹤0.01% 3986
2021
Q2 		$1.49M Buy
936
+592
+172% +$900K ﹤0.01% 4050
2021
Q1 		$520K Buy
344
+29
+9% +$43.8K ﹤0.01% 4129
2020
Q4 		$335K Hold
315
– – ﹤0.01% 4024
2020
Q3 		$439K Sell
315
-138
-30% -$129K ﹤0.01% 3836
2020
Q2 		$393K Hold
453
– – ﹤0.01% 3820
2020
Q1 		$368K Hold
453
– – ﹤0.01% 3734
2019
Q4 		$682K Hold
453
– – ﹤0.01% 3730
2019
Q3 		$424K Sell
453
-17
-4% -$18.1K ﹤0.01% 3848
2019
Q2 		$494K Sell
470
-16
-3% -$23.9K ﹤0.01% 3829
2019
Q1 		$1.04M Buy
486
+424
+684% +$1.26M ﹤0.01% 3620
2018
Q4 		$200K Buy
+62
New +$99.1K ﹤0.01% 3904

Other funds holding AZR

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Vanguard Group's AZR Position: Q4 2025 in Review

Vanguard Group held its Azora Therapeutics, Inc. Common Stock (AZR) position steady in Q4 2025 at 6,241 shares worth $34.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4277.

Vanguard Group first reported a position in AZR in Q4 2018 and has held it in 23 quarters since. The position peaked at $2.55M in Q3 2021. 23 funds tracked by Wall St. Rank hold AZR as of Q4 2025.

  • Vanguard Group held 6,241 shares of Azora Therapeutics, Inc. Common Stock worth $34.3K as of Q4 2025.
  • Vanguard Group left its Azora Therapeutics, Inc. Common Stock share count unchanged in Q4 2025.
  • Azora Therapeutics, Inc. Common Stock made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4277 holding.
  • Vanguard Group first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2018 and has held it in 23 quarters since.
  • Vanguard Group's Azora Therapeutics, Inc. Common Stock position peaked at $2.55M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.